By Ludwig Burger
FRANKFURT (Reuters) – Swiss drugs and diagnostics company Roche said on Thursday it is targeting an increase in core 2025 earnings per share in a high single-digit percentage range, when adjusted for currency swings.
(Reporting by Ludwig Burger, Editing by Rachel More)